The expression of mesenchymal marker Vimentin and the matrix metalloproteinase 2 (MMP-2) which degrades and remodels the extracellular matrix (ECM) was increased in most of the osteosarcoma cell lines. This evidence concerns the gene MMP2 and osteosarcoma.